These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 11099478)
21. Upregulation of Cdc2 and cyclin A during apoptosis of endothelial cells induced by cleaved high-molecular-weight kininogen. Wang S; Hasham MG; Isordia-Salas I; Tsygankov AY; Colman RW; Guo YL Am J Physiol Heart Circ Physiol; 2003 Jun; 284(6):H1917-23. PubMed ID: 12742823 [TBL] [Abstract][Full Text] [Related]
22. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF. Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784 [TBL] [Abstract][Full Text] [Related]
23. Role of the light chain of high molecular weight kininogen in adhesion, cell-associated proteolysis and angiogenesis. Colman RW Biol Chem; 2001 Jan; 382(1):65-70. PubMed ID: 11258675 [TBL] [Abstract][Full Text] [Related]
24. High-molecular-weight kininogen fragments stimulate the secretion of cytokines and chemokines through uPAR, Mac-1, and gC1qR in monocytes. Khan MM; Bradford HN; Isordia-Salas I; Liu Y; Wu Y; Espinola RG; Ghebrehiwet B; Colman RW Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2260-6. PubMed ID: 16902163 [TBL] [Abstract][Full Text] [Related]
25. Cleaved high molecular weight kininogen inhibits tube formation of endothelial progenitor cells via suppression of matrix metalloproteinase 2. Wu Y; Dai J; Schmuckler NG; Bakdash N; Yoder MC; Overall CM; Colman RW J Thromb Haemost; 2010 Jan; 8(1):185-93. PubMed ID: 19874467 [TBL] [Abstract][Full Text] [Related]
26. High molecular weight kininogen binds to laminin--characterization and kinetic analysis. Schousboe I; Nystrøm B FEBS J; 2009 Sep; 276(18):5228-38. PubMed ID: 19691495 [TBL] [Abstract][Full Text] [Related]
27. Canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth. He GA; Luo JX; Zhang TY; Wang FY; Li RF Biochem Biophys Res Commun; 2003 Dec; 312(3):801-5. PubMed ID: 14680836 [TBL] [Abstract][Full Text] [Related]
28. Kininostatin, an angiogenic inhibitor, inhibits proliferation and induces apoptosis of human endothelial cells. Guo YL; Wang S; Colman RW Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1427-33. PubMed ID: 11557667 [TBL] [Abstract][Full Text] [Related]
29. Novel role for p56/Lck in regulation of endothelial cell survival and angiogenesis. Betapudi V; Shukla M; Alluri R; Merkulov S; McCrae KR FASEB J; 2016 Oct; 30(10):3515-3526. PubMed ID: 27402674 [TBL] [Abstract][Full Text] [Related]
30. High molecular weight kininogen and factor XII binding to endothelial cells and astrocytes. Fernando LP; Natesan S; Joseph K; Kaplan AP Thromb Haemost; 2003 Nov; 90(5):787-95. PubMed ID: 14597972 [TBL] [Abstract][Full Text] [Related]
31. Interaction of high-molecular-weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by surface plasmon resonance (BiaCore). Pixley RA; Espinola RG; Ghebrehiwet B; Joseph K; Kao A; Bdeir K; Cines DB; Colman RW Thromb Haemost; 2011 Jun; 105(6):1053-9. PubMed ID: 21544310 [TBL] [Abstract][Full Text] [Related]
32. Cleaved high-molecular-weight kininogen and its domain 5 inhibit migration and invasion of human prostate cancer cells through the epidermal growth factor receptor pathway. Liu Y; Pixley R; Fusaro M; Godoy G; Kim E; Bromberg ME; Colman RW Oncogene; 2009 Jul; 28(30):2756-65. PubMed ID: 19483730 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of contact activation by a kininogen peptide (HKH20) derived from domain 5. Nakazawa Y; Joseph K; Kaplan AP Int Immunopharmacol; 2002 Dec; 2(13-14):1875-85. PubMed ID: 12494915 [TBL] [Abstract][Full Text] [Related]
34. Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells. Joseph K; Ghebrehiwet B; Kaplan AP Clin Immunol; 1999 Sep; 92(3):246-55. PubMed ID: 10479529 [TBL] [Abstract][Full Text] [Related]
35. Ferritin blocks inhibitory effects of two-chain high molecular weight kininogen (HKa) on adhesion and survival signaling in endothelial cells. Tesfay L; Huhn AJ; Hatcher H; Torti FM; Torti SV PLoS One; 2012; 7(7):e40030. PubMed ID: 22768328 [TBL] [Abstract][Full Text] [Related]
36. The contact system and angiogenesis: potential for therapeutic control of malignancy. Colman RW Semin Thromb Hemost; 2004 Feb; 30(1):45-61. PubMed ID: 15034797 [TBL] [Abstract][Full Text] [Related]
37. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells. He GA; Luo JX; Zhang TY; Hu ZS; Wang FY Biochem Biophys Res Commun; 2004 May; 318(2):354-60. PubMed ID: 15120609 [TBL] [Abstract][Full Text] [Related]
38. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor. Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116 [TBL] [Abstract][Full Text] [Related]
39. Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis. Jia H; Lohr M; Jezequel S; Davis D; Shaikh S; Selwood D; Zachary I Biochem Biophys Res Commun; 2001 May; 283(2):469-79. PubMed ID: 11327725 [TBL] [Abstract][Full Text] [Related]
40. High molecular weight kininogen peptides inhibit the formation of kallikrein on endothelial cell surfaces and subsequent urokinase-dependent plasmin formation. Lin Y; Harris RB; Yan W; McCrae KR; Zhang H; Colman RW Blood; 1997 Jul; 90(2):690-7. PubMed ID: 9226169 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]